CL2024002418A1 - Uso de roluperidona en la prevención de recaídas en pacientes con esquizofrenia - Google Patents

Uso de roluperidona en la prevención de recaídas en pacientes con esquizofrenia

Info

Publication number
CL2024002418A1
CL2024002418A1 CL2024002418A CL2024002418A CL2024002418A1 CL 2024002418 A1 CL2024002418 A1 CL 2024002418A1 CL 2024002418 A CL2024002418 A CL 2024002418A CL 2024002418 A CL2024002418 A CL 2024002418A CL 2024002418 A1 CL2024002418 A1 CL 2024002418A1
Authority
CL
Chile
Prior art keywords
schizophrenia
roluperidone
patients
relapses
prevention
Prior art date
Application number
CL2024002418A
Other languages
English (en)
Spanish (es)
Inventor
Luthringer Remy
Original Assignee
Minerva Neurosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minerva Neurosciences Inc filed Critical Minerva Neurosciences Inc
Publication of CL2024002418A1 publication Critical patent/CL2024002418A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CL2024002418A 2022-02-14 2024-08-12 Uso de roluperidona en la prevención de recaídas en pacientes con esquizofrenia CL2024002418A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202263309874P 2022-02-14 2022-02-14

Publications (1)

Publication Number Publication Date
CL2024002418A1 true CL2024002418A1 (es) 2024-12-13

Family

ID=85569991

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2024002418A CL2024002418A1 (es) 2022-02-14 2024-08-12 Uso de roluperidona en la prevención de recaídas en pacientes con esquizofrenia

Country Status (12)

Country Link
US (1) US20230255953A1 (https=)
EP (2) EP4479049B1 (https=)
JP (1) JP2025505261A (https=)
KR (1) KR20240161650A (https=)
CN (1) CN118984705A (https=)
AU (1) AU2023217097A1 (https=)
CA (1) CA3243767A1 (https=)
CL (1) CL2024002418A1 (https=)
ES (1) ES3064313T3 (https=)
IL (1) IL314859A (https=)
MX (1) MX2024009828A (https=)
WO (1) WO2023154927A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL319156A (en) 2017-06-21 2025-04-01 Minerva Neurosciences Inc Controlled-release oral dosage forms are resistant to gastric acid.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166617B2 (en) 2000-02-29 2007-01-23 Mitsubishi Pharma Corporation Cyclic amide derivatives
PL3227273T3 (pl) 2014-12-02 2022-05-30 Minerva Neurosciences, Inc. Kompozycje zawierające 2-((1-(2-(4-fluorofenylo)-2-oksoetylo)piperydyn-4-ylo)metylo)izoindolin-1-on do leczenia schizofrenii
IL319156A (en) 2017-06-21 2025-04-01 Minerva Neurosciences Inc Controlled-release oral dosage forms are resistant to gastric acid.
WO2020264486A1 (en) * 2019-06-28 2020-12-30 Teva Czech Industries S.R.O Solid state forms of roluperidone and salts thereof

Also Published As

Publication number Publication date
CA3243767A1 (en) 2023-08-17
WO2023154927A1 (en) 2023-08-17
EP4479049B1 (en) 2025-12-17
US20230255953A1 (en) 2023-08-17
EP4729122A2 (en) 2026-04-22
JP2025505261A (ja) 2025-02-21
IL314859A (en) 2024-10-01
AU2023217097A1 (en) 2024-08-29
EP4479049A1 (en) 2024-12-25
CN118984705A (zh) 2024-11-19
ES3064313T3 (en) 2026-04-23
MX2024009828A (es) 2024-11-08
KR20240161650A (ko) 2024-11-12

Similar Documents

Publication Publication Date Title
MX2025011553A (es) Composiciones para inducir la hidrolisis de ras gtp y sus usos
DOP2023000187A (es) Anticuerpos que se dirigen al gp120 de vih y métodos de uso
CO2020013600A2 (es) Tratamiento de la hidradenitis supurativa mediante el uso de inhibidores de jak
CL2023002497A1 (es) Uso de inhibidores de bet como tratamiento para la mielofibrosis
BR112022026186A2 (pt) Combinação de um inibidor de bromodomínio cbp/p300 e um inibidor de kras
UY31017A1 (es) Uso de un inhibidor del factor &(alfa) de necrosis tumoral mas un antihistaminico para el tratamiento de la rinitis alérgica y la conjuntivitis alérgica.
CO5611176A2 (es) Administracion de agentes para el tratamiento de inflamacion
MX2016004580A (es) Uso de un inhibidor de pcsk9 para tratar la hiperlipidemia.
CL2008003901A1 (es) Uso de un inhibidor de hedgehog para extender la sobrevida libre de recidiva en un paciente con cancer, que se encuentra en quimioterapia o ha sido tratado previamente con quimioterapia.
MX2022010357A (es) Anticuerpos inhibidores de anti-pcsk9 para el tratamiento de pacientes con hiperlipidemia que se someten aferesis de lipoproteina.
CL2024002418A1 (es) Uso de roluperidona en la prevención de recaídas en pacientes con esquizofrenia
CL2021000924A1 (es) Uso de reboxetina para el tratamiento de narcolepsia
MX2024004216A (es) Terapias combinadas de inhibidores de kras g12d con inhibidores de la familia pan erbb.
BRPI0513168A (pt) memantina como tratamento adjunto para antipsicóticos atìpicos em pacientes com esquizofrenia
UY39510A (es) Compuestos macrocíclicos y métodos para usarlos
BR112023007912A2 (pt) Formas cristalinas de um composto inibidor de kras g12c
BR112023002883A2 (pt) Conjunto de composições para tratamento bucal anticárie
CL2025002366A1 (es) Compuesto que contiene trifluorometilsulfonilo.
CO2022015428A2 (es) Compuesto de oxofenilarsina deuterada y uso del mismo
MX2025013118A (es) Tratamiento combinado para una enfermedad o un trastorno relacionado con ras
BR112021018815A2 (pt) Gepotidacina para uso no tratamento de infecções bacterianas do trato urinário
CL2021000627A1 (es) Composiciones farmacéuticas adecuadas para liberación articular y su uso en el tratamiento del dolor articular
BR112022008610A2 (pt) Composições tópicas compreendendo inibidores de irak4 para uso em tratamento de condições dermatológicas caracterizadas por inflamação
HN2011000661A (es) Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual
UY40481A (es) Composición líquida de dalbavancina